Nicola J. Lawrence
Lifehouse Level 6, 119-143 Missenden Road
Camperdown, NSW 2050, Australia
Camperdown, NSW 2050, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Practice Change Following Small Trials in Rare Cancers With Rare Biomarkers.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 19, 2026
Informed acceptance and perceptions of the 2025 ILAE seizure classification following structured teaching.
Journal: Epileptic disorders : international epilepsy journal with videotape
Published: April 24, 2026
Real-World Outcomes in Advanced Clear Cell Renal Cell Carcinoma: A Retrospective Analysis Comparing New Zealand and Australian Cohorts.
Journal: JCO global oncology
Published: March 06, 2026
Radiographic Progression Without Prostate-specific Antigen Progression in Metastatic Hormone-sensitive Prostate Cancer: A Retrospective Analysis of the ENZAMET Trial (ANZUP 1304).
Journal: European urology oncology
Published: November 10, 2025
Pacific Peoples' Experiences of Cancer and Its Treatment in Aotearoa New Zealand Through Talanoa: A Qualitative Study of Samoan and Tongan Participants.
Journal: JCO global oncology
Published: January 03, 2025
Process of development of decentralised clinical trial methodology for cancer clinical trials in Aotearoa New Zealand.
Journal: The New Zealand medical journal
Published: December 12, 2024
PAM trial protocol: a randomised feasibility study of psychedelic microdosing-assisted meaning-centred psychotherapy in advanced stage cancer patients.
Journal: Pilot and feasibility studies
Published: June 28, 2023
Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial.
Journal: The Lancet. Oncology
Published: December 05, 2022
The perceptions of cancer health-care practitioners in New Zealand and the USA toward psychedelic-assisted therapy with cancer patients: A cross-sectional survey.
Journal: Palliative & supportive care
Published: November 03, 2022
Efficacy and Safety of Telaglenastat Plus Cabozantinib vs Placebo Plus Cabozantinib in Patients With Advanced Renal Cell Carcinoma: The CANTATA Randomized Clinical Trial.
Journal: JAMA oncology
Published: September 01, 2022
Health-Related Quality of Life in Metastatic, Hormone-Sensitive Prostate Cancer: ENZAMET (ANZUP 1304), an International, Randomized Phase III Trial Led by ANZUP.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 20, 2021
Overall Survival of Men with Metachronous Metastatic Hormone-sensitive Prostate Cancer Treated with Enzalutamide and Androgen Deprivation Therapy.
Journal: European urology
Published: February 28, 2021
Last Updated: 09/26/2026